Both teams have little to fight for. Ipswich will be without key players such as Wesley Burns, Jaden Philogene-Bidace, and Chiedozie Ogbene. Samuel Szmodics has a chance to feature before the ...

As tariffs stoke fears of supply-chain disruptions, here’s where Vanguard sees demand for bonds Tariffs are a ‘double-edged sword,’ says Vanguard’s Rebecca Venter ...

They also have an extensive injury list, including goalkeeper Arijanet Muric (who has been out since February 27 with a shoulder injury), winger Jaden Philogene-Bidace (MCL), midfielder Kalvin ...

Ipswich took the lead less than five minutes into proceedings after a calamitous mix-up between Patrick Dorgu and Andre Onana allowed Jaden Philogene-Bidace an easy goal. United fought back, ...

You can reach Adam on Signal at stataf.54. Biogen and Stoke Therapeutics have signed a partnership agreement to co-develop and sell Stoke’s experimental treatment for Dravet syndrome ...

Y Combinator alum Stoke Space just raised a $260 million Series C, bringing its total raised to $480 million. This follows $100 million raised in October 2023, and $75 million in December 2021.

Investment to fund development of Stoke’s fully reusable Nova launch vehicle and completion of launch facility at Cape Canaveral Space Force Station KENT, Wash., January 15, 2025--(BUSINESS WIRE ...

Stoke Space is developing Nova, a medium-class launch vehicles whose two stages are both designed to be reusable. Credit: Stoke Space WASHINGTON — Stoke Space has raised $260 million to advance ...

The Stoke Space rocket engine test lights up a vertical test stand in Moses Lake, Wash. (Stoke Space Photo) Stoke Space successfully hotfired its first-stage rocket engine on a new vertical test ...

Stoke Space is nothing if not ambitious. The five-year-old launch startup has generated a lot of hype due to its bold plans to develop the first fully reusable rocket, with both the booster and ...

Stoke Therapeutics’ Dravet syndrome drug has been freed from a partial hold, clearing the way for the construction of a phase 3 program. While studies for STK-001, now known as zorevunersen, had ...